LoginSignup
Cronos Group logo

Cronos Group Stock

StockStock
ISIN: CA22717L1013
Ticker: CRON
CA22717L1013
CRON

Price

Frequently asked questions

What is Cronos Group's market capitalization?

The market capitalization of Cronos Group is $826.71M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Cronos Group?

Cronos Group's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.124. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Cronos Group's stock?

Currently, 7 analysts cover Cronos Group's stock, with a consensus target price of $2.86. Analyst ratings provide insights into the stock's expected performance.

What is Cronos Group's revenue over the trailing twelve months?

Over the trailing twelve months, Cronos Group reported a revenue of $110.69M.

What is the EBITDA for Cronos Group?

Cronos Group's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$58.57M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Cronos Group?

Cronos Group has a free cash flow of $17.53M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Cronos Group's stock?

The 5-year beta for Cronos Group is 1.06. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Cronos Group have, and what sector and industry does it belong to?

Cronos Group employs approximately 626 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Cronos Group's shares?

The free float of Cronos Group is 200.37M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $826.71M

5Y beta

 1.06

EPS (TTM)

 -$0.124

Free Float

 200.37M

Revenue (TTM)

 $110.69M

EBITDA (TTM)

 -$58.57M

Free Cashflow (TTM)

 $17.53M

Pricing

1D span
$2.066$2.219
52W span
$1.851$3.143

Analyst Ratings

The price target is $2.86 and the stock is covered by 7 analysts.

Buy

3

Hold

3

Sell

1

Information

Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company operates through one segment, which is comprised of operations in Canada and Israel and is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, and Lord Jones. The Spinach brand offers pre-rolls infused with cold-filtered cannabis extract and coated in kief, and all-in-one disposable vapes. The Lord Jones is a hemp-derived cannabidiol (CBD) brand. Its Lord Jones Hash Fusions are a line-up of premium ice water hash infused pre-rolls. This brand also offers vapes and edibles. Its PEACE NATURALS offer Peppermint CBD, a blend of CBD extract, quality medium-chain triglycerides (MCT) oil, and a hint of natural peppermint flavor.

626

Biotechnology & Drugs

Health Care

Identifier

ISIN

CA22717L1013

Primary Ticker

CRON

Knockouts

Join the conversation
Sign upLogin